What is the recommended dose of amitriptyline (tricyclic antidepressant) for migraine prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amitriptyline Dosing for Migraine Prophylaxis

For migraine prevention, start amitriptyline at 10-25 mg at bedtime and titrate gradually to a target dose of 30-150 mg daily, with most patients achieving benefit at 50-100 mg daily. 1, 2

Starting and Titration Strategy

  • Begin with 10-25 mg at bedtime and increase slowly over weeks to months to minimize side effects and improve tolerability 1
  • The FDA-approved outpatient starting regimen is 75 mg daily in divided doses, though clinical practice typically starts lower for prophylaxis 2
  • An alternative initiation method is 50-100 mg at bedtime, increased by 25-50 mg increments as needed 2

Target Therapeutic Dose

  • The recommended therapeutic range is 30-150 mg daily for migraine prophylaxis 1, 3
  • Most patients respond adequately to 50-100 mg daily, which should be the initial target 1
  • Some patients may require up to 150 mg daily if lower doses prove insufficient 1, 2
  • Hospitalized patients may need higher doses (100-200 mg daily), with rare cases requiring up to 300 mg daily 2

Timeline for Response

  • Clinical benefits may not become apparent for 2-3 months after reaching therapeutic dosing 1, 4
  • An adequate trial requires maintaining the target dose for at least 2-3 months before declaring treatment failure 1
  • Sedative effects may appear before the therapeutic effect on headache frequency 2

Maintenance and Duration

  • Once satisfactory improvement is achieved, the usual maintenance dose is 50-100 mg daily (some patients respond to as little as 40 mg daily) 2
  • The total daily dose can be given as a single bedtime dose for convenience 2
  • Continue treatment for 6-12 months, then attempt to taper to the lowest effective dose or discontinue 1, 5

Patient Selection Considerations

  • Amitriptyline is superior to propranolol for patients with mixed migraine and tension-type headache 1
  • For pure migraine without tension-type features, propranolol may be preferred over amitriptyline 1
  • Consider amitriptyline as first-line in patients with comorbid depression or tension-type headaches 5, 3

Special Populations

  • Adolescents and elderly patients: Start with 10 mg three times daily plus 20 mg at bedtime (total 50 mg daily) if higher doses are not tolerated 2
  • Pediatric patients (≥12 years): Use 1 mg/kg daily as the target dose, with 84% of children showing improvement and minimal side effects 6
  • Not recommended for children under 12 years due to lack of experience 2

Common Side Effects to Anticipate

  • Weight gain, drowsiness, and anticholinergic symptoms (dry mouth, constipation) are the most frequent adverse effects 1
  • These side effects often necessitate the low-start, slow-titration approach 1
  • Plasma level monitoring may be useful in elderly patients or when toxicity is suspected, though dosing should be based on clinical response 2

Important Clinical Caveats

  • Limit acute migraine medication use to no more than twice weekly to prevent medication-overuse headaches, even when on prophylaxis 7
  • If amitriptyline proves ineffective or poorly tolerated after an adequate trial, consider switching to beta-blockers (propranolol 80-240 mg daily) or anticonvulsants (topiramate 50-200 mg daily, divalproex sodium 600-1500 mg daily) 1, 4
  • Patients should maintain a headache diary to objectively assess treatment response 4, 8

References

Guideline

Preventative Treatments for Occipital Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Prevention with Topiramate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Prophylactic treatments of migraine].

Revue neurologique, 2000

Guideline

Migraine Cocktail Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.